Stay updated on Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The AMEERA-3 breast cancer trial record is now available with study design, eligibility criteria, locations, outcome measures, and supporting documents. It reports that the study was terminated by sponsor decision and is no longer recruiting participants.
    Difference
    100%
    Check dated 2026-11-08T14:32:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:46:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:41:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T15:46:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:29:27.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a basic error screen (including a Home button and site footer).
    Difference
    20%
    Check dated 2026-09-20T10:36:42.000Z thumbnail image

Stay in the know with updates to Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.